Clinical Trial Search

Primary: Number of Participants With Parenteral Nutrition Associated Cholestasis — 6; 6 Participants — p=0.94

Primary: Change From Baseline/Visit 2 (Day 1) in Bulbar Conjunctival Hyperemia at Visit 4 (Day 15) — -0.3812; -0.2371 score on a scale

Primary: Fluid Balance — 0.65; 2.02 Liters — p=0.021

Primary: Change in Bleeding at Specified Time Intervals — 485.7; 199.1 seconds

Primary: Safety and Feasibility of Applying Light Therapy After Moderate TBI — 24; 19 Participants

Primary: Change in KCCQ Physical Limitation Score From Baseline to Week 24 — 6.41; 5.47; 6.93 Scores on a scale — p== 0.8008

Primary: Number of Participants With a Response — 198; 3; 4 Participants

Primary: Infection Rate — 5; 6; 3; 0 Participants

Primary: Plasma PCSK9 Levels at Baseline and End of 6 Week Intervention — 13.30; 14.11; 12.44 ng/mL

Primary: Progression-Free Survival Rate at 16 Weeks Following Treatment With CS-1008 in Combination With Gemcitabine in Chemotherapy-Naïve Participants With Unresectable or…

Primary: Insulin Prescription Rate - the Number of Insulin-eligible Patients Per 12 Months Who Are Prescribed Insulin in Each Family Physician (FP) Practice — 2.28; 2.29 patients…

Primary: Change From Baseline in Glycosylated Hemoglobin A1c (HbA1c) to Week 24 (Controlled Assessment Period) — -0.36; 0.49 percentage (% HbA1c) — p=0.012

Primary: Insulin Sensitivity With PREDIM (PREDIcted M) Index — 72.48 index

Primary: Participants With Detectable RSV Shedding in Nasopharyngeal Wash — 2; 4 Participants

Primary: Change From Pre- to 6 Months Post-implantation Speech Recognition in Quiet in the Implanted Ear Alone — 14.6; 60.9 percentage of correct words